Julie Carnis

VP and Head of Rare Oncology at SERB Pharmaceuticals

Speaker

Julie Carnis is VP and Head of Rare Oncology at SERB Pharmaceuticals, where she leads U.S. strategy and commercialization with full P&L accountability across a growing rare oncology portfolio.

She brings over 14 years of experience across M&A, corporate strategy, and global product launches, with a track record of driving growth and value creation in specialty and rare disease markets. She previously played a key role in the U.S. launch of Dupixent in Gastroenterology.

Julie has held leadership roles across North America, Europe, and Asia, and is known for bridging strategy and execution to unlock commercial opportunities in complex markets.